Clinical trial
A Randomized Multicenter Trial of Accelerated Hypo - vs. Normo-fractionated Radiotherapy for Head and Neck Squamous Cell Carcinoma (IAEA-HYPNO Trial)
NCT02765503 is registered in ClinicalTrials.gov with International Atomic Energy Agency as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Multicenter Trial of Accelerated Hypo - vs. Normo-fractionated Radiotherapy for Head and Neck Squamous Cell Carcinoma (IAEA-HYPNO Trial)
- Lead sponsor
- International Atomic Energy Agency
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- March 31, 2014
- Completion date
- November 30, 2021
- Enrollment
- 836 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
squamous cell carcinoma of the head and neck